Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 0.336\% hERG inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a: Cc1cc(C)n(C(=O)CNc2ccc(C)c(C)c2)n1
b: Cc1ccc(-c2cc(C(=O)NCCCN3CCOCC3)c3ccc(Cl)c(C)c3n2)cc1
c: CC(Cc1cnccn1)NCc1c(C(=O)N2CCCCCCC2)nc2ccc(Cl)cn12
Answer: c. CC(Cc1cnccn1)NCc1c(C(=O)N2CCCCCCC2)nc2ccc(Cl)cn12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(Cc1cnccn1)NCc1c(C(=O)N2CCCCCCC2)nc2ccc(Cl)cn12
CC(Cc1cnccn1)NCc1c(C(=O)N2CCCCCCC2)nc2ccc(Cl)cn12
azocan-1-yl-[6-chloro-3-[(1-pyrazin-2-ylpropan-2-ylamino)methyl]imidazo[1,2-a]pyridin-2-yl]methanone